BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Reis CP, Veiga FJ, Ribeiro AJ, Neufeld RJ, Damgé C. Nanoparticulate biopolymers deliver insulin orally eliciting pharmacological response. J Pharm Sci. 2008;97:5290-5305. [PMID: 18384153 DOI: 10.1002/jps.21347] [Cited by in Crossref: 65] [Cited by in F6Publishing: 57] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Rekha MR, Sharma CP. Oral delivery of therapeutic protein/peptide for diabetes--future perspectives. Int J Pharm 2013;440:48-62. [PMID: 22503954 DOI: 10.1016/j.ijpharm.2012.03.056] [Cited by in Crossref: 102] [Cited by in F6Publishing: 91] [Article Influence: 10.2] [Reference Citation Analysis]
2 Rijo P, Falé PL, Serralheiro M, Simões M, Gomes A, Reis C. Optimization of medicinal plant extraction methods and their encapsulation through extrusion technology. Measurement 2014;58:249-55. [DOI: 10.1016/j.measurement.2014.08.045] [Cited by in Crossref: 30] [Cited by in F6Publishing: 10] [Article Influence: 3.8] [Reference Citation Analysis]
3 Miao YB, Lin YJ, Chen KH, Luo PK, Chuang SH, Yu YT, Tai HM, Chen CT, Lin KJ, Sung HW. Engineering Nano- and Microparticles as Oral Delivery Vehicles to Promote Intestinal Lymphatic Drug Transport. Adv Mater 2021;:e2104139. [PMID: 34596293 DOI: 10.1002/adma.202104139] [Reference Citation Analysis]
4 Pinelo R, Roque L, Reis CP. Oral insulin delivery: utopia, currently possible or a near reality? Ther Deliv 2021;12:477-88. [PMID: 34008413 DOI: 10.4155/tde-2021-0021] [Reference Citation Analysis]
5 Fonte P, Andrade F, Araújo F, Andrade C, Neves JD, Sarmento B. Chitosan-Coated Solid Lipid Nanoparticles for Insulin Delivery. Nanomedicine - Cancer, Diabetes, and Cardiovascular, Central Nervous System, Pulmonary and Inflammatory Diseases. Elsevier; 2012. pp. 295-314. [DOI: 10.1016/b978-0-12-391860-4.00015-x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 10] [Article Influence: 5.6] [Reference Citation Analysis]
6 Sharma G, Sharma AR, Nam JS, Doss GP, Lee SS, Chakraborty C. Nanoparticle based insulin delivery system: the next generation efficient therapy for Type 1 diabetes. J Nanobiotechnology 2015;13:74. [PMID: 26498972 DOI: 10.1186/s12951-015-0136-y] [Cited by in Crossref: 85] [Cited by in F6Publishing: 67] [Article Influence: 12.1] [Reference Citation Analysis]
7 Card JW, Magnuson BA. A review of the efficacy and safety of nanoparticle-based oral insulin delivery systems. Am J Physiol Gastrointest Liver Physiol 2011;301:G956-67. [PMID: 21921287 DOI: 10.1152/ajpgi.00107.2011] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
8 Bowey K, Swift BE, Flynn LE, Neufeld RJ. Characterization of biologically active insulin-loaded alginate microparticles prepared by spray drying. Drug Development and Industrial Pharmacy 2012;39:457-65. [DOI: 10.3109/03639045.2012.662985] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
9 Lopes MA, Abrahim BA, Cabral LM, Rodrigues CR, Seiça RMF, de Baptista Veiga FJ, Ribeiro AJ. Intestinal absorption of insulin nanoparticles: Contribution of M cells. Nanomedicine: Nanotechnology, Biology and Medicine 2014;10:1139-51. [DOI: 10.1016/j.nano.2014.02.014] [Cited by in Crossref: 59] [Cited by in F6Publishing: 53] [Article Influence: 7.4] [Reference Citation Analysis]
10 Damgé C, Socha M, Ubrich N, Maincent P. Poly(epsilon-caprolactone)/eudragit nanoparticles for oral delivery of aspart-insulin in the treatment of diabetes. J Pharm Sci 2010;99:879-89. [PMID: 19691099 DOI: 10.1002/jps.21874] [Cited by in Crossref: 57] [Cited by in F6Publishing: 49] [Article Influence: 4.8] [Reference Citation Analysis]
11 Woitiski CB, Veiga F, Ribeiro A, Neufeld R. Design for optimization of nanoparticles integrating biomaterials for orally dosed insulin. European Journal of Pharmaceutics and Biopharmaceutics 2009;73:25-33. [DOI: 10.1016/j.ejpb.2009.06.002] [Cited by in Crossref: 71] [Cited by in F6Publishing: 67] [Article Influence: 5.5] [Reference Citation Analysis]
12 Ramesan RM, Sharma CP. Challenges and advances in nanoparticle-based oral insulin delivery. Expert Review of Medical Devices 2014;6:665-76. [DOI: 10.1586/erd.09.43] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 5.8] [Reference Citation Analysis]
13 Yoshida K, Hasebe Y, Takahashi S, Sato K, Anzai J. Layer-by-layer deposited nano- and micro-assemblies for insulin delivery: A review. Materials Science and Engineering: C 2014;34:384-92. [DOI: 10.1016/j.msec.2013.09.045] [Cited by in Crossref: 60] [Cited by in F6Publishing: 51] [Article Influence: 7.5] [Reference Citation Analysis]
14 Santalices I, Gonella A, Torres D, Alonso MJ. Advances on the formulation of proteins using nanotechnologies. Journal of Drug Delivery Science and Technology 2017;42:155-80. [DOI: 10.1016/j.jddst.2017.06.018] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 3.8] [Reference Citation Analysis]
15 Lakkireddy HR, Urmann M, Besenius M, Werner U, Haack T, Brun P, Alié J, Illel B, Hortala L, Vogel R, Bazile D. Oral delivery of diabetes peptides - Comparing standard formulations incorporating functional excipients and nanotechnologies in the translational context. Adv Drug Deliv Rev 2016;106:196-222. [PMID: 26964477 DOI: 10.1016/j.addr.2016.02.011] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 6.7] [Reference Citation Analysis]
16 Pechenkin MA, Balabushevich NG, Zorov IN, Izumrudov VA, Klyachko NL, Kabanov AV, Larionova NI. Use of Protease Inhibitors in Composite Polyelectrolyte Microparticles in Order to Increase the Bioavailability of Perorally Administered Encapsulated Proteins. Pharm Chem J 2013;47:62-9. [DOI: 10.1007/s11094-013-0898-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
17 Reis CP, Neufeld RJ, Veiga F, Ribeiro AJ. Chapter 7: Preparation of Drug‒Loaded Polymeric Nanoparticles. In: Balogh L, editor. Nanomedicine in Cancer. 6000 Broken Sound Parkway NW: CRC Press; 2017. pp. 171-214. [DOI: 10.1201/9781315114361-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.6] [Reference Citation Analysis]
18 Lopes M, Derenne A, Pereira C, Veiga F, Seiça R, Sarmento B, Ribeiro A. Impact of the in vitro gastrointestinal passage of biopolymer-based nanoparticles on insulin absorption. RSC Adv 2016;6:20155-65. [DOI: 10.1039/c5ra26224k] [Cited by in Crossref: 11] [Article Influence: 1.8] [Reference Citation Analysis]
19 Maher S, Leonard TW, Jacobsen J, Brayden DJ. Safety and efficacy of sodium caprate in promoting oral drug absorption: from in vitro to the clinic. Advanced Drug Delivery Reviews 2009;61:1427-49. [DOI: 10.1016/j.addr.2009.09.006] [Cited by in Crossref: 143] [Cited by in F6Publishing: 131] [Article Influence: 11.0] [Reference Citation Analysis]
20 Woitiski CB, Sarmento B, Carvalho RA, Neufeld RJ, Veiga F. Facilitated nanoscale delivery of insulin across intestinal membrane models. Int J Pharm 2011;412:123-31. [PMID: 21501675 DOI: 10.1016/j.ijpharm.2011.04.003] [Cited by in Crossref: 89] [Cited by in F6Publishing: 77] [Article Influence: 8.1] [Reference Citation Analysis]
21 Fonte P, Nogueira T, Gehm C, Ferreira D, Sarmento B. Chitosan-coated solid lipid nanoparticles enhance the oral absorption of insulin. Drug Deliv and Transl Res 2011;1:299-308. [DOI: 10.1007/s13346-011-0023-5] [Cited by in Crossref: 109] [Cited by in F6Publishing: 94] [Article Influence: 9.9] [Reference Citation Analysis]
22 Mokhtari S, Jafari SM, Assadpour E. Development of a nutraceutical nano-delivery system through emulsification/internal gelation of alginate. Food Chemistry 2017;229:286-95. [DOI: 10.1016/j.foodchem.2017.02.071] [Cited by in Crossref: 77] [Cited by in F6Publishing: 46] [Article Influence: 15.4] [Reference Citation Analysis]
23 Paques JP. Alginate Nanospheres Prepared by Internal or External Gelation with Nanoparticles. Microencapsulation and Microspheres for Food Applications. Elsevier; 2015. pp. 39-55. [DOI: 10.1016/b978-0-12-800350-3.00004-2] [Cited by in Crossref: 6] [Article Influence: 0.9] [Reference Citation Analysis]
24 Bianchera A, Bettini R. Polysaccharide nanoparticles for oral controlled drug delivery: the role of drug-polymer and interpolymer interactions. Expert Opin Drug Deliv 2020;17:1345-59. [PMID: 32602795 DOI: 10.1080/17425247.2020.1789585] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
25 Sosnik A, das Neves J, Sarmento B. Mucoadhesive polymers in the design of nano-drug delivery systems for administration by non-parenteral routes: A review. Progress in Polymer Science 2014;39:2030-75. [DOI: 10.1016/j.progpolymsci.2014.07.010] [Cited by in Crossref: 287] [Cited by in F6Publishing: 215] [Article Influence: 35.9] [Reference Citation Analysis]
26 Tao C, Chuah YJ, Xu C, Wang DA. Albumin conjugates and assemblies as versatile bio-functional additives and carriers for biomedical applications. J Mater Chem B 2019;7:357-67. [PMID: 32254722 DOI: 10.1039/c8tb02477d] [Cited by in Crossref: 23] [Cited by in F6Publishing: 5] [Article Influence: 5.8] [Reference Citation Analysis]
27 Song L, Zhi ZL, Pickup JC. Nanolayer encapsulation of insulin-chitosan complexes improves efficiency of oral insulin delivery. Int J Nanomedicine 2014;9:2127-36. [PMID: 24833901 DOI: 10.2147/IJN.S59075] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
28 Feng C, Wang Z, Jiang C, Kong M, Zhou X, Li Y, Cheng X, Chen X. Chitosan/o-carboxymethyl chitosan nanoparticles for efficient and safe oral anticancer drug delivery: In vitro and in vivo evaluation. International Journal of Pharmaceutics 2013;457:158-67. [DOI: 10.1016/j.ijpharm.2013.07.079] [Cited by in Crossref: 151] [Cited by in F6Publishing: 125] [Article Influence: 16.8] [Reference Citation Analysis]
29 Reis CP, Roque LV, Baptista M, Rijo P. Innovative formulation of nystatin particulate systems in toothpaste for candidiasis treatment. Pharmaceutical Development and Technology 2016;21:282-7. [DOI: 10.3109/10837450.2014.999783] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
30 Russell-Jones G. Intestinal receptor targeting for peptide delivery: an expert's personal perspective on reasons for failure and new opportunities. Ther Deliv 2011;2:1575-93. [PMID: 22833983 DOI: 10.4155/tde.11.129] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
31 Doostmohammadi M, Ameri A, Mohammadinejad R, Dehghannoudeh N, Banat IM, Ohadi M, Dehghannoudeh G. Hydrogels For Peptide Hormones Delivery: Therapeutic And Tissue Engineering Applications. Drug Des Devel Ther 2019;13:3405-18. [PMID: 31579238 DOI: 10.2147/DDDT.S217211] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
32 Reis C, Martinho N, Damgé C. Nanotechnology for Oral Drug Delivery and Targeting. In: Arias J, editor. Nanotechnology and Drug Delivery, Volume Two. CRC Press; 2016. pp. 20-51. [DOI: 10.1201/b19976-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
33 Reis CP, Neufeld R, Veiga F, Figueiredo IV, Jones J, Soares AF, Nunes P, Damgé C, Carvalho RA. Effects of an oral insulin nanoparticle administration on hepatic glucose metabolism assessed by 13 C and 2 H isotopomer analysis. Journal of Microencapsulation 2011;29:167-76. [DOI: 10.3109/02652048.2011.638992] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
34 Lopes M, Aniceto D, Abrantes M, Simões S, Branco F, Vitória I, Botelho MF, Seiça R, Veiga F, Ribeiro A. In vivo biodistribution of antihyperglycemic biopolymer-based nanoparticles for the treatment of type 1 and type 2 diabetes. European Journal of Pharmaceutics and Biopharmaceutics 2017;113:88-96. [DOI: 10.1016/j.ejpb.2016.11.037] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
35 Reis CP, Damgé C. Nanotechnology as a promising strategy for alternative routes of insulin delivery. Methods Enzymol 2012;508:271-94. [PMID: 22449931 DOI: 10.1016/B978-0-12-391860-4.00014-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
36 Lalatsa A, Schatzlein AG, Uchegbu IF. Strategies to deliver peptide drugs to the brain. Mol Pharm 2014;11:1081-93. [PMID: 24601686 DOI: 10.1021/mp400680d] [Cited by in Crossref: 84] [Cited by in F6Publishing: 70] [Article Influence: 10.5] [Reference Citation Analysis]
37 de Almeida TS, Caparica R, Júlio A, Reis CP. An Overview on Ionic Liquids: A New Frontier for Nanopharmaceuticals. In: Yata VK, Ranjan S, Dasgupta N, Lichtfouse E, editors. Nanopharmaceuticals: Principles and Applications Vol. 1. Cham: Springer International Publishing; 2021. pp. 181-204. [DOI: 10.1007/978-3-030-44925-4_5] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
38 Chan AW, Neufeld RJ. Tuneable semi-synthetic network alginate for absorptive encapsulation and controlled release of protein therapeutics. Biomaterials 2010;31:9040-7. [DOI: 10.1016/j.biomaterials.2010.07.111] [Cited by in Crossref: 76] [Cited by in F6Publishing: 55] [Article Influence: 6.3] [Reference Citation Analysis]
39 Herrero EP, Alonso MJ, Csaba N. Polymer-based oral peptide nanomedicines. Therapeutic Delivery 2012;3:657-68. [DOI: 10.4155/tde.12.40] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 4.2] [Reference Citation Analysis]
40 Zhang Z, Nix CA, Ercan UK, Gerstenhaber JA, Joshi SG, Zhong Y. Calcium binding-mediated sustained release of minocycline from hydrophilic multilayer coatings targeting infection and inflammation. PLoS One 2014;9:e84360. [PMID: 24409292 DOI: 10.1371/journal.pone.0084360] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
41 Rijo P, Matias D, Fernandes A, Simões M, Nicolai M, Reis C. Antimicrobial Plant Extracts Encapsulated into Polymeric Beads for Potential Application on the Skin. Polymers 2014;6:479-90. [DOI: 10.3390/polym6020479] [Cited by in Crossref: 42] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
42 Woitiski CB, Neufeld RJ, Veiga F, Carvalho RA, Figueiredo IV. Pharmacological effect of orally delivered insulin facilitated by multilayered stable nanoparticles. European Journal of Pharmaceutical Sciences 2010;41:556-63. [DOI: 10.1016/j.ejps.2010.08.009] [Cited by in Crossref: 84] [Cited by in F6Publishing: 75] [Article Influence: 7.0] [Reference Citation Analysis]
43 Siwach R, Pandey P, Chawla V, Dureja H. Role of Nanotechnology in Diabetic Management. Recent Pat Nanotechnol 2019;13:28-37. [PMID: 30608045 DOI: 10.2174/1872210513666190104122032] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
44 Mudassir J, Darwis Y, Khiang PK. Prerequisite Characteristics of Nanocarriers Favoring Oral Insulin Delivery: Nanogels as an Opportunity. International Journal of Polymeric Materials and Polymeric Biomaterials 2014;64:155-67. [DOI: 10.1080/00914037.2014.921919] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
45 Wu T, Zheng WL, Zhang SZ, Sun JH, Yuan H. Bimodal visualization of colorectal uptake of nanoparticles in dimethylhydrazine-treated mice. World J Gastroenterol 2011; 17(31): 3614-3622 [PMID: 21987608 DOI: 10.3748/wjg.v17.i31.3614] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
46 Amaral M, Martins AS, Catarino J, Faísca P, Kumar P, Pinto JF, Pinto R, Correia I, Ascensão L, Afonso RA, Gaspar MM, Charmier AJ, Figueiredo IV, Reis CP. How Can Biomolecules Improve Mucoadhesion of Oral Insulin? A Comprehensive Insight using Ex-Vivo, In Silico, and In Vivo Models. Biomolecules 2020;10:E675. [PMID: 32349416 DOI: 10.3390/biom10050675] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
47 Sonia TA, Sharma CP. Polymers in oral insulin delivery. Oral Delivery of Insulin. Elsevier; 2014. pp. 257-310. [DOI: 10.1533/9781908818683.257] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
48 Nur M, Vasiljevic T. Can natural polymers assist in delivering insulin orally? Int J Biol Macromol 2017;103:889-901. [PMID: 28552728 DOI: 10.1016/j.ijbiomac.2017.05.138] [Cited by in Crossref: 33] [Cited by in F6Publishing: 22] [Article Influence: 6.6] [Reference Citation Analysis]
49 Paques JP, van der Linden E, van Rijn CJ, Sagis LM. Preparation methods of alginate nanoparticles. Advances in Colloid and Interface Science 2014;209:163-71. [DOI: 10.1016/j.cis.2014.03.009] [Cited by in Crossref: 228] [Cited by in F6Publishing: 168] [Article Influence: 28.5] [Reference Citation Analysis]
50 Lopes M, Shrestha N, Correia A, Shahbazi MA, Sarmento B, Hirvonen J, Veiga F, Seiça R, Ribeiro A, Santos HA. Dual chitosan/albumin-coated alginate/dextran sulfate nanoparticles for enhanced oral delivery of insulin. J Control Release 2016;232:29-41. [PMID: 27074369 DOI: 10.1016/j.jconrel.2016.04.012] [Cited by in Crossref: 115] [Cited by in F6Publishing: 97] [Article Influence: 19.2] [Reference Citation Analysis]
51 Costache AD, Sheihet L, Zaveri K, Knight DD, Kohn J. Polymer-drug interactions in tyrosine-derived triblock copolymer nanospheres: a computational modeling approach. Mol Pharm 2009;6:1620-7. [PMID: 19650665 DOI: 10.1021/mp900114w] [Cited by in Crossref: 56] [Cited by in F6Publishing: 49] [Article Influence: 4.3] [Reference Citation Analysis]
52 Bahman F, Greish K, Taurin S. Nanotechnology in Insulin Delivery for Management of Diabetes. Pharm Nanotechnol 2019;7:113-28. [PMID: 30907328 DOI: 10.2174/2211738507666190321110721] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
53 Mahjub R, Dorkoosh FA, Amini M, Khoshayand MR, Rafiee-Tehrani M. Preparation, statistical optimization, and in vitro characterization of insulin nanoparticles composed of quaternized aromatic derivatives of chitosan. AAPS PharmSciTech 2011;12:1407-19. [PMID: 22033812 DOI: 10.1208/s12249-011-9716-9] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 3.5] [Reference Citation Analysis]
54 de Almeida TS, Júlio A, Mota JP, Rijo P, Reis CP. An emerging integration between ionic liquids and nanotechnology: general uses and future prospects in drug delivery. Ther Deliv 2017;8:461-73. [PMID: 28530146 DOI: 10.4155/tde-2017-0002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 5.3] [Reference Citation Analysis]
55 Morales-Burgos AM, Carvajal-Millan E, Sotelo-Cruz N, Rascón-Chu A, Lizardi-Mendoza J, López-Franco YL, Martínez-Porchas M, Canett-Romero R. Highly cross-linked arabinoxylans microspheres as a microbiota-activated carrier for colon-specific insulin delivery. Eur J Pharm Biopharm 2021;163:16-22. [PMID: 33774161 DOI: 10.1016/j.ejpb.2021.02.014] [Reference Citation Analysis]
56 Yazdanpanah A, Rezvani Z, Ramedani A, Gholipourmalekabadi M, Chauhan NPS, Moztarzadeh S, Urbanska A, Mozafari M. Nanobiomaterials set to revolutionize drug-delivery systems for the treatment of diabetes. Nanobiomaterials in Drug Delivery. Elsevier; 2016. pp. 487-514. [DOI: 10.1016/b978-0-323-42866-8.00014-9] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
57 Mansourpour M, Mahjub R, Amini M, Ostad SN, Shamsa ES, Rafiee-Tehrani M, Dorkoosh FA. Development of acid-resistant alginate/trimethyl chitosan nanoparticles containing cationic β-cyclodextrin polymers for insulin oral delivery. AAPS PharmSciTech 2015;16:952-62. [PMID: 25604700 DOI: 10.1208/s12249-014-0282-9] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 5.4] [Reference Citation Analysis]
58 Lim HP, Tey BT, Chan ES. Particle designs for the stabilization and controlled-delivery of protein drugs by biopolymers: a case study on insulin. J Control Release 2014;186:11-21. [PMID: 24816070 DOI: 10.1016/j.jconrel.2014.04.042] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 5.9] [Reference Citation Analysis]
59 Roque L, Duarte N, Bronze MR, Garcia C, Alopaeus J, Molpeceres J, Hagesaether E, Tho I, Rijo P, Reis C. Development of a bioadhesive nanoformulation with Glycyrrhiza glabra L. extract against Candida albicans. Biofouling 2018;34:880-92. [PMID: 30362371 DOI: 10.1080/08927014.2018.1514391] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]